HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Magnetic field assisted α-Fe2O3/Zn1-xFexO heterojunctions for accelerating antiviral agents degradation under visible-light.

Abstract
Reducing the recombination efficiency of photo-induced carriers has been found as an effective means to improve the degradation of antiviral agents. Given that the Lorentz forces can cause the abnormal charge to move in the opposite direction, external magnetic field improved α-Fe2O3/Zn1-xFexO heterojunctions (FZHx) were developed to remove increasing antiviral agents that were attributed to the COVID-19 pandemic under visible light. The characterization of the mentioned FZHx in the external magnetic field indicated that FZHx had perfect photocatalytic activity for degrading antiviral agents. In the external magnetic field, the quantities of photo-generated carriers and free radicals (•OH and •O2 -) derived from FZHx increased significantly, which improved antiviral agent removal by 30.0%. Though the band structure (α-Fe2O3) is unlikely to change due to some orders of magnitude weaker of Zeeman energy in magnetic fields, which insignificantly impacts photocatalytic performance. However, this study proposed a strategy of negative magnetoresistance effects and heterojunctions to facilitate the separation and transfer of photo-induced carriers in magnetic fields. Based on the proposed strategy, spin oriented electrons were selected and accumulated on the conduction band, which contributed to the degradation of antiviral agents. Overall, this study presented novel insights into the improved degradation performance of antiviral agents by applying Fe-based heterojunctions in an external magnetic field.
AuthorsYadong Wu, Tao Li, Xulin Ren, Yuanxiang Fu, Hongyan Zhang, Xiaoqing Feng, Hongsheng Huang, Ruishi Xie
JournalJournal of environmental chemical engineering (J Environ Chem Eng) Vol. 10 Issue 1 Pg. 106990 (Feb 2022) ISSN: 2213-2929 [Print] Netherlands
PMID34926145 (Publication Type: Journal Article)
Copyright© 2021 Elsevier Ltd. All rights reserved.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: